Publicação: Infliximab-induced psoriasis during therapy for Crohn's disease
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Elsevier B.V.
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon. (C) 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Descrição
Palavras-chave
Biological therapy, Crohn's disease, Infliximab, Psoriasis, Tumor necrosis factor-alpha inhibitors
Idioma
Inglês
Como citar
Journal of Crohns & Colitis. Amsterdam: Elsevier B.V., v. 6, n. 5, p. 610-616, 2012.
